Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Tracey TJ, Steyn FJ, Wolvetang EJ, Ngo ST. Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease. Front Mol Neurosci. 2018;11:10. Jan 23
Hryhorczuk C, Florea M, Rodaros D, Poirier I, Daneault C, Des Rosiers C, et al. Dampened mesolimbic dopamine function and signaling by saturated but not monounsaturated dietary lipids. Neuropsychopharmacology. 2015;41:811–21.
Décarie-Spain L, Sharma S, Hryhorczuk C, Issa-Garcia V, Barker PA, Arbour N, et al. Nucleus accumbens inflammation mediates anxiodepressive behavior and compulsive sucrose seeking elicited by saturated dietary fat. Mol Metab. 2018;10:1–13.
Cansell C, Castel J, Denis RG, Rouch C, Delbes AS, Martinez S, et al. Dietary triglycerides act on mesolimbic structures to regulate the rewarding and motivational aspects of feeding. Mol Psychiatry. 2014;19:1095–105.
Hryhorczuk C, Sheng Z, Décarie-Spain L, Giguère N, Bourque M, Trudeau L-E, et al. Oleic acid in the ventral tegmental area inhibits feeding, food reward and dopamine tone. Neuropsychopharmacology. 2018;43:607–16.
Karmi A, Iozzo P, Viljanen A, Hirvonen J, Fielding BA, Virtanen K, et al. Increased brain fatty acid uptake in metabolic syndrome. Diabetes. 2010;59:2171–7.
Acknowledgements
SF and TA are both supported by FRQS scholar awards. Research was supported by a CIHR operating grant to SF (#275314). Many thanks to the Cecile Hryhorczuk, Léa Décarie-Spain and Sandeep Sharma for their hard work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fulton, S., Alquier, T. Lipid signalling in the mesolimbic dopamine pathway. Neuropsychopharmacol 44, 221–222 (2019). https://doi.org/10.1038/s41386-018-0188-4
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41386-018-0188-4